Universitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2022

  1. Validation of a commercial allergen microarray platform for specific immunoglobulin E detection of respiratory and plant food allergens

    Annals of Allergy, Asthma and Immunology, Vol. 128, Núm. 3, pp. 283-290.e4

2020

  1. Diagnostic capacity of commercial extracts vs prick-by-prick in the study of sensitization to peanut: Which technique should we use?

    Journal of Investigational Allergology and Clinical Immunology, Vol. 30, Núm. 5, pp. 373-375

  2. Identification and Characterization of IgE-Reactive Proteins and a New Allergen (Cic a 1.01) from Chickpea (Cicer arietinum)

    Molecular Nutrition and Food Research, Vol. 64, Núm. 19

2017

  1. Mechanisms, cofactors, and augmenting factors involved in anaphylaxis

    Frontiers in Immunology

2016

  1. Clinical performance of commercial ISAC 112 allergen microarray versus noncommercial RIRAAF platform for the diagnosis of plant food and olive pollen allergies

    Journal of Investigational Allergology and Clinical Immunology

  2. Comparable actions of omalizumab on mast cells and basophils

    Clinical and Experimental Allergy, Vol. 46, Núm. 1, pp. 92-102

  3. Is microarray analysis really useful and sufficient to diagnose nut allergy in the Mediterranean area?

    Journal of Investigational Allergology and Clinical Immunology, Vol. 26, Núm. 1, pp. 31-39

  4. Is the ISAC 112 microarray useful in the diagnosis of pollinosis in Spain?

    Journal of Investigational Allergology and Clinical Immunology, Vol. 26, Núm. 2, pp. 92-99

  5. Is the performance of ImmunoCAP ISAC 112 sufficient to diagnose peach and apple allergies?

    Annals of Allergy, Asthma and Immunology, Vol. 116, Núm. 2, pp. 162-163